• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Dedicare: Exceptional growth in Norway cools off - ABG

DEDIEksterne analyser13.02.2024, 14.46

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
Sweden still affected by cautious hiring policy
Positive development in UK
Normalisation before next growth phase?


Q4: Net sales -7% y-o-y, adj. EBIT margin of 6.1% (6.7%)

Dedicare reported Q4 net sales of SEK 464m (-7% y-o-y), which was 14% below ABGSCe as we did not foresee the slower pace in Norway in the quarter. Denmark was also behind our expectations as a hiring freeze for nurses on long-term contracts was introduced. Sweden was still affected by the more cautious hiring policy in some regions. This might change for the better in '24 as the new national framework agreement has been passed after it was challenged in court. We think the regions might have waited for the outcome of that court decision before deciding their hiring policies going forward. UK had a strong Q4 and Dedicare announced a few framework wins in the region that should set it up for a solid '24 as well. EBIT of SEK 39.3m (31.3m) was better than ABGSCe but it was also positively affected by a write-down of earn-outs, which should be treated as an IAC. Adj. EBIT was SEK 28.4m, 17% below ABGSCe.